| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.042 | 0.1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.045 | 0.1 |